Arben Ventures backs early‑stage deep‑tech health startups that are redefining personalized medicine through precision medicine, multi‑omics and innovative medical devices. The firm focuses on areas such as early cancer detection, women’s health, mental health and longevity, seeking founders at the intersection of biology and technology. By providing $25‑50K initial checks (up to $500K follow‑on), Arben aims to accelerate breakthroughs that improve global health outcomes.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
55.9%United Kingdom
8.5%Canada
3.4%Israel
1.7%India
1.7%Other
6.8%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Pre-Seed → Seed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Check sizes
Min: $25K
Typical: $50K
Max: $500K